Professor Tolias focuses his research on:

  • STRUCTURAL AND COMPUTATIONAL (COMPUTER-BASED) DRUG DISCOVERY
  • ASSAY DEVELOPMENT AND ROBOTIC DRUG SCREENING
  • GENE CLONING, PRODUCTION AND PURIFICATION OF THERAPEUTIC PROTEINS AND TARGETS
  • CELLULAR ASSAYS AND 3D TISSUE ENGINEERING
  • PERSONALIZED MEDICINE, GENOMICS, MODELING, DIAGNOSIS AND TREATMENT OF DISEASE

He is currently Director of the university-wide Center for Healthcare Innovation and a Professor in the Department of Chemistry, Chemical Biology and Biomedical Engineering at the Stevens Institute of Technology. He is the recipient of over three dozen grants, contracts, awards and honors, the co-founder of several diagnostic and biotechnology companies and holds board and scientific advisory memberships on scientific journals, corporations, non-profits and universities.

Dr. Tolias was formerly the Executive Director of the Institute of Genomic Medicine, Research Director of the Autism Center and Professor of Pediatrics at the New Jersey Medical School. Previously, he served as Worldwide Vice President of Advanced Research and Technology Assessment, at Ortho-Clinical Diagnostics - a Johnson & Johnson company - and Executive Vice President of Corporate Development at Rosetta Genomics. Earlier in his career, he was an Associate Professor of Microbiology & Molecular Genetics at the New Jersey Medical School, an Associate Member of the Public Health Research Institute and earlier as an Assistant Member. He obtained his Ph.D. from McGill University, was a post-doctoral fellow at Harvard University and received executive training at the Wharton Business School of University of Pennsylvania.